PANCREATIC CARCINOMA RECURRENT

This adverse event was reported 241 times

These drugs are most commonly taken by patients reporting PANCREATIC CARCINOMA RECURRENT:

# Drug Count
0 PANCRELIPASE 68
1 GEMCITABINE HYDROCHLORIDE 28
2 GEMCITABINE 25
3 FLUOROURACIL 24
4 FLUOROURACIL CREAM, 0.5% 24
5 SITAGLIPTIN 22
6 PACLITAXEL 19
7 OXALIPLATIN 17
8 LANSOPRAZOLE 13
9 PACLITAXEL (AIBUMIN-BOUND) 13
See all common drugs associated with PANCREATIC CARCINOMA RECURRENT

PANCREATIC CARCINOMA RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ACID REDUCER 1 0.0039
1 FAMOTIDINE 20MG 1 0.0027
2 PANCRELIPASE 68 0.0017
3 ALDESLEUKIN 1 0.0008
4 ETHIODIZED OIL 1 0.0008
5 MEPERIDINE HYDROCHLORIDE 6 0.0006
6 IRINOTECAN HYDROCHLORIDE 8 0.0006
7 ENTRECTINIB 1 0.0006
8 GEMCITABINE HYDROCHLORIDE 28 0.0005
9 GLUCAGON 2 0.0005
See all drugs enriched for association with PANCREATIC CARCINOMA RECURRENT

PANCREATIC CARCINOMA RECURRENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Adrenal Steroid Synthesis Inhibitor [EPC] 1 0.0010
1 Lymphocyte Growth Factor [EPC] 1 0.0008
2 Interferon gamma [EPC] 1 0.0007
3 Antihypoglycemic Agent [EPC] 2 0.0005
4 CCR5 Co-receptor Antagonist [EPC] 1 0.0004
5 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 8 0.0004
6 Cannabinoid [EPC] 2 0.0002
7 Provitamin D2 Compound [EPC] 7 0.0002
8 Phenothiazine [EPC] 7 0.0002
9 Bile Acid [EPC] 5 0.0002
See all drug classes enriched for association with PANCREATIC CARCINOMA RECURRENT